MMNNF yields 0.95% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, MMNNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MMNNF + JNJ for your $10,000?
Munters Group AB (publ) provides climate solutions for customers in Sweden and internationally. It offers air intakes/air inlets, combined temperature and humidity control products, dehumidifiers, heat exchangers, mass transfer solutions and equipment, pollution control and VOC abatements, climate and irrigation controllers for agriculture, coolers and humidifiers, fans and light traps, heaters, and mist eliminators. The company also provides installation support, start-up and commissioning, service agreement and maintenance, training, and rental solutions, as well as rotor performance check, reconditioning and repair, spare parts, controls upgrade, rotor replacement, munters rotor energy recovery, and fan motor upgrade services. It serves agriculture, automotive, battery dry rooms, chemical processing, construction, data centers, defense and aerospace, electronics, food and beverage, general industry/production, greenhouse, healthcare, pharmaceutical, power generation and distribution, recreation and leisure, shipbuilding and marine, steel, temporary structures, and water and wastewater; oil, gas, and petroleum; pulp, paper, and printing; and storage, preservation, and archives industries. Munters Group AB (publ) was founded in 1955 and is headquartered in Kista, Sweden.
Full MMNNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.